Core Viewpoint - HaiXi New Drug (02637) announced its investment strategy to utilize idle funds effectively by subscribing to structured notes and a fund, aiming to enhance capital returns while ensuring liquidity and meeting operational needs [1] Group 1: Investment Details - The company plans to invest HKD 200 million in structured notes issued by Essence Global Investment Limited under its USD 1 billion secured structured note program [1] - Additionally, the company will subscribe up to HKD 200 million in China Rock Fund SPC, collectively referred to as the subscription matters [1] Group 2: Financial Strategy - The investment aligns with the company's core objective of improving capital returns while ensuring the safety and liquidity of funds [1] - The strategy also aims to meet the group's daily operational and dividend payment funding requirements [1]

智通财经APP讯，海西新药(02637)发布公告，于2025年10月24日，福建海西新药创制股份有限公司(本 公司)作为投资者，动用其闲置资金，认购(i)2亿港元由Essence Global Investment Limited根据其10亿美 元有担保结构性票据计划发行的2025-32系列基金挂钩票据(基金挂鈎票据)(认购基金挂钩票据);及(ii)最 多2亿港元的China Rock Fund SPC(认购China Rock Fund，连同认购基金挂钩票据称为认购事项)。 合理有效地利用临时闲置资金可提高本公司的资本收益，与本公司确保资金安全和流动性以及满足本集 团日常运营及股息派付的资金需求这一核心目标一致。 ...

Trading Information - As of January 19, 2026, Zhonghong Medical (300981) closed at 13.39 yuan, up 0.75%, with a turnover rate of 0.89% and a trading volume of 34,900 shares, amounting to 46.4462 million yuan [1] - On January 19, 2026, the net outflow of main funds was 2.9472 million yuan, while retail investors saw a net inflow of 0.9156 million yuan [1] Company Announcements - Zhonghong Medical announced it will provide a guarantee of 50 million yuan for its wholly-owned subsidiary, Zhonghong International (Hong Kong) Trading Co., Ltd., in a financing contract with China Construction Bank [1] - The guarantee period is three years from the maturity of the main debt, and the subsidiary's latest asset-liability ratio is 94% [1] - The total guarantee amount for the company and its subsidiaries is 735 million yuan, accounting for 13.43% of the latest audited net assets, with no overdue guarantees [1] Board Meeting Resolutions - On January 19, 2026, Zhonghong Medical held its 16th meeting of the fourth board of directors, approving several proposals including the use of idle funds for low-risk financial products and foreign exchange derivatives trading [2] - The proposals will be submitted for approval at the first extraordinary shareholders' meeting of 2026, scheduled for February 5, 2026 [2] Financial Management Strategies - The company plans to invest up to 2 billion yuan of idle self-owned funds in low-risk financial products with a maximum investment period of 36 months [5] - The investment will focus on R1 and R2 rated financial products issued by commercial banks, trusts, and other financial institutions [5] - The company aims to conduct commodity futures hedging with a maximum trading margin of 5 million yuan and a total trading amount not exceeding 50 million yuan, using self-owned funds [3][4] Foreign Exchange Derivatives Trading - Zhonghong Medical intends to engage in foreign exchange derivatives trading to mitigate exchange rate risks, with a maximum balance of 500 million USD at any time [3][4] - The trading will include foreign exchange forwards, swaps, and options, with the funds sourced from self-owned capital [4]

Group 1 - The core point of the article is that Jin Yi Technology (002869) plans to invest 100 million yuan of its idle funds into a private equity fund to enhance the efficiency of its capital usage without affecting its daily operational funds [1] Group 2 - The company aims to utilize idle self-owned funds to improve financial efficiency [1] - The investment will be made in the Hengbang Shouzheng Chuqing private equity securities investment fund [1] - The decision reflects the company's strategy to optimize resource allocation while maintaining operational liquidity [1]

Core Viewpoint - The company plans to invest 100 million yuan in a private equity fund to enhance the efficiency of idle funds, indicating a strategic move to optimize asset management [1] Group 1: Investment Details - The company intends to purchase shares in the Hengbang Shouzheng Chuqing private equity fund [1] - The fund was registered on March 9, 2021, and has a risk level classified as R4 [1] - The expected duration of the fund is 10 years from its establishment [1] Group 2: Contractual Agreements - The company has signed relevant contracts with Hengbang Zhaofeng and Industrial Securities [1] - This investment does not require approval from the board of directors or shareholders [1] Group 3: Risk Management - The investment is subject to various risks, including potential capital loss and market risks [1] - The company will enhance its risk control measures in light of these potential risks [1]

Core Viewpoint - The company has approved the use of idle self-owned funds to invest in low-risk financial products and government bond reverse repos, with a maximum amount of RMB 50 million, to enhance the efficiency of fund utilization and create greater value for the company and its shareholders [3][10][19]. Group 1: Board Meeting Details - The 13th meeting of the 7th Board of Directors was held on December 28, 2025, with all 9 directors present, and was conducted in compliance with relevant laws and regulations [2][4]. - The meeting was chaired by Chairman Tao Xucheng and included senior management in attendance [2]. Group 2: Investment Proposal - The board approved the proposal to use idle self-owned funds for purchasing financial products and engaging in government bond reverse repos, with a total investment limit of RMB 50 million [3][10]. - The investment aims to improve the efficiency of idle funds while ensuring the company's operational and project investment needs are met [10][19]. Group 3: Investment Details - The investment will focus on low-risk financial products issued by banks or securities companies rated A or above by the China Securities Regulatory Commission, with a maturity of no more than 12 months [9][12]. - The authorized investment period is valid for 12 months from the date of board approval [13]. Group 4: Financial Management - The funds for this investment will come from the company's idle self-owned funds and will not involve raised funds or bank credit [14]. - The company will maintain a strict evaluation process for the financial products to mitigate risks associated with market fluctuations [16]. Group 5: Impact on Company Operations - The investment in financial products and government bond reverse repos will not adversely affect the company's daily operations or project investments, and is expected to enhance the efficiency of idle fund utilization [19].

Core Viewpoint - Pingtan Development (000592.SZ) announced plans to enhance the efficiency of fund utilization by investing idle self-owned funds in short-term financial products, aiming to increase returns while ensuring operational liquidity and safety [1] Group 1: Investment Strategy - The company intends to invest temporarily idle self-owned funds in high-security, liquid financial products issued by banks and securities firms [1] - The maximum amount allocated for purchasing financial products will not exceed RMB 500 million, including the principal [1] - Funds within this limit can be used on a rolling basis [1]

Group 1 - The company, Youfa Group, announced on December 10 that it will hold the 24th meeting of the fifth board of directors on December 10, 2025, to approve the proposal for using idle self-owned funds to purchase financial products, with an investment amount not exceeding 2.5 billion yuan [1] - In 2024, the revenue composition of Youfa Group is projected to be 91.62% from the metal products industry and 8.38% from other businesses [1] - The current market capitalization of Youfa Group is 9.5 billion yuan [2]

Core Viewpoint - The company, Guiding Compass, announced a capital increase of 100 million yuan to its wholly-owned subsidiary, Mai Gao Securities, following the failure of a previous 2.9 billion yuan fundraising plan [2][5]. Group 1: Capital Increase - Guiding Compass plans to increase the registered capital of Mai Gao Securities from 1.4 billion yuan to 1.5 billion yuan [5]. - The capital increase aims to better meet the funding needs for the business development of Mai Gao Securities, contributing to stable business progress and aligning with the company's long-term planning and core interests [5]. Group 2: Financial Impact - The funding for the capital increase will come from the company's own funds and is not expected to significantly impact the current financial status or operating results of Guiding Compass [5]. - The company also announced a plan to use up to 300 million yuan of idle funds to purchase bonds, aiming to improve capital efficiency and increase shareholder returns [5]. Group 3: Background of Mai Gao Securities - Mai Gao Securities, formerly known as Wangxin Securities, was acquired by Guiding Compass in 2022 after undergoing bankruptcy reorganization [5]. - The company had previously proposed a fundraising plan to raise up to 2.9 billion yuan, which was ultimately terminated on October 31 due to various internal and external factors [5]. Group 4: Recent Performance - Mai Gao Securities has begun to recover from previous years of losses, reporting a revenue of 324 million yuan and a net profit of 70.36 million yuan in the first half of 2025 [6]. - For the first three quarters of 2025, the company achieved a net income from fees and commissions of 366 million yuan, a year-on-year increase of 171.07%, and net interest income of 70.84 million yuan, up 54.46% [6].

Core Viewpoint - The company, Guiding Compass, is increasing its wholly-owned subsidiary, Maigao Securities, by 100 million yuan to support its business development needs after a failed 2.9 billion yuan fundraising attempt [2][5][6]. Group 1: Capital Increase - Guiding Compass announced a capital increase of 100 million yuan for Maigao Securities, raising its registered capital from 1.4 billion yuan to 1.5 billion yuan [5]. - The capital increase aims to better meet the funding needs of Maigao Securities and is aligned with the company's long-term planning and core interests [5][6]. Group 2: Previous Fundraising Attempt - The previous fundraising plan, which aimed to raise up to 2.9 billion yuan, was terminated after three years due to various internal and external factors [6]. - The decision to terminate the fundraising was made after careful analysis and consideration of the company's strategic goals [6]. Group 3: Financial Performance of Maigao Securities - Maigao Securities has begun to recover from previous years of losses, reporting a revenue of 324 million yuan and a net profit of 70.36 million yuan in the first half of 2025 [6]. - For the first three quarters of 2025, Maigao Securities achieved a net income from fees and commissions of 366 million yuan, a year-on-year increase of 171.07% [6]. - The net interest income for the same period was 70.84 million yuan, reflecting a growth of 54.46% year-on-year [6].